Page 137 - 南京医科大学自然版

第45卷第8期 钱 哲，臧 攀，丁 磊，等. 高危前列腺癌患者穿刺病理预测模型的构建及验证研究［J］.
2025年8月 南京医科大学学报（自然科学版），2025，45（8）：1186-1193，1210 ·1193 ·

梁超和丁磊参与本文的审核和修改；钱哲对数据进行分析并 plate⁃guided prostate biopsy：10 years of experience［J］.
撰写了本文。 BJU Int，2016，117（3）：424-429
Author’s Contributions： ［12］DONG J X，ZHAO X H，WANG Y，et al. Evaluation on di⁃
QIAN Zhe，ZANG Pan and WANG Yuhao collected the da⁃ agnostic value of ultrasonic elastography parameters and
ta；LI Jie provided theoretical guidance；LIANG Chao and DING serum testosterone in the diagnosis of prostate cancer［J］.
Lei were involved in reviewing and revising this paper；QIAN Arch Esp Urol，2023，76（9）：674-679
Zhe analyzed the data and wrote the paper. ［13］GIROMETTI R，GIANNARINI G，PERUZZI V，et al. MRI
⁃ informed prostate biopsy：what the radiologist should
［参考文献］
know on quality in biopsy planning and biopsy acquisi⁃
［1］ WANG F Q，WANG C C，XIA H F，et al. Burden of pros⁃
tion［J］. Eur J Radiol，2023，164：110852
tate cancer in China，1990⁃2019：findings from the 2019
［14］AHDOOT M，WILBUR A R，REESE S E，et al. MRI⁃tar⁃
global burden of disease study［J］. Front Endocrinol（Lau⁃
geted，systematic，and combined biopsy for prostate can⁃
sanne），2022，13：853623
cer diagnosis［J］. N Engl J Med，2020，382（10）：917-928
［2］ FERNANDES M C，YILDIRIM O，WOO S，et al. The role
［15］ZLOTTA A R，EGAWA S，PUSHKAR D，et al. Preva⁃
of MRI in prostate cancer：current and future directions［J］.
lence of prostate cancer on autopsy：cross⁃sectional study
MAGMA，2022，35（4）：503－521
on unscreened Caucasian and Asian men［J］. J Natl Can⁃
［3］ O’SHEA A，HARISINGHANI M. PI⁃RADS：Multipara⁃
cer Inst，2013，105（14）：1050-1058
metric MRI in prostate cancer［J］. Magn Reson Mater
［16］GE Q Y，ZHANG S C，XU H W，et al. Development and
Phys Biol Med，2022，35（4）：523-532 validation of a novel nomogram predicting clinically sig⁃
［4］ SONG G，RUAN M J，WANG H，et al. How many targeted nificant prostate cancer in biopsy ⁃ naive men based on
biopsy cores are needed for clinically significant prostate multi ⁃ institutional analysis［J］. Cancer Med，2023，12
cancer detection during transperineal magnetic resonance （24）：21820-21829
imaging ultrasound fusion biopsy?［J］. J Urol，2020，204 ［17］FUKUI Y D，YAMADA Y，SAKAMOTO S，et al. Preoper⁃
（6）：1202-1208 ative PI⁃RADS v2.1 scoring system improves risk classifi⁃
［5］ AHMED H U，BOSAILY A E，BROWN L C，et al. Diag⁃ cation in patients undergoing radical prostatectomy［J］.
nostic accuracy of multi⁃parametric MRI and TRUS biopsy Anticancer Res，2023，43（12）：5705-5712
in prostate cancer（PROMIS）：a paired validating confir⁃ ［18］GOMEZ⁃GOMEZ E，MORENO S S，VALERO⁃ROSA J，et
matory study［J］. Lancet，2017，389（10071）：815-822 al. Does adding standard systematic biopsy to targeted
［6］ KASIVISVANATHAN V，RANNIKKO A S，BORGHI M， prostate biopsy in PI⁃RADS 3 to 5 lesions enhance the de⁃
et al. MRI⁃targeted or standard biopsy for prostate⁃cancer tection of clinically significant prostate cancer?Should all
diagnosis［J］. N Engl J Med，2018，378（19）：1767-1777 patients with PI⁃RADS 3 undergo targeted biopsy?［J］. Di⁃
［7］ WEN J，TANG T T，JI Y G，et al. PI⁃RADS v2.1 com⁃ agnostics（Basel），2021，11（8）：1335
bined with prostate⁃specific antigen density for detection ［19］YU X D，LIU R J，SONG L Y，et al. Differences in the
of prostate cancer in peripheral zone［J］. Front Oncol， pathogenetic characteristics of prostate cancer in the tran⁃
2022，12：861928 sitional and peripheral zones and the possible molecular
［8］ HUANG J Q，HE C，XU P R，et al. Development and vali⁃ biological mechanisms［J］. Front Oncol，2023，13：
dation of a clinical⁃radiomics model for prediction of pros⁃ 1165732
tate cancer：a multicenter study［J］. World J Urol，2024， ［20］PORPIGLIA F，CHECCUCCI E，DE CILLIS S，et al. A
42（1）：275 prospective randomized controlled trial comparing target
［9］ MEYER A R，MAMAWALA M，WINOKER J S，et al. prostate biopsy alone approach vs. target plus standard in
Transperineal prostate biopsy improves the detection of naïve patients with positive mpMRI［J］. Minerva Urol
clinically significant prostate cancer among men on active Nephrol，2023，75（1）：31-41
surveillance［J］. J Urol，2021，205（4）：1069-1074 ［21］LACSON R，HAJ⁃MIRZAIAN A，BURK K，et al. A model
［10］CONNOR M J，ELDRED⁃EVANS D，VAN SON M，et al. for predicting clinically significant prostate cancer using
A multicenter study of the clinical utility of nontargeted prostate MRI and risk factors［J］. J Am Coll Radiol，2024，
systematic transperineal prostate biopsies in patients un⁃ 21（9）：1419-1427
dergoing pre⁃biopsy multiparametric magnetic resonance ［22］ZHAO W J，HOU M Y，WANG J，et al. Interpretable ma⁃
imaging［J］. J Urol，2020，204（6）：1195-1201 chine learning model for predicting clinically significant
［11］MAI Z P，YAN W G，ZHOU Y，et al. Transperineal tem⁃ （下转第1210页）